API issues are affecting the production of semaglutide products involving Torrent Pharmaceuticals and Dr. Reddy’s Laboratories.
1 report, 1 independent
Updated Sep 15
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
API issues are affecting the production of semaglutide products involving Torrent Pharmaceuticals and Dr. Reddy’s Laboratories.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Torrent Pharmaceuticals
Indian multinational pharmaceutical company
- FDA
Related events
- FDA and state authorities are investigating product manufacturers in Utah.
- Unicycive Therapeutics, Inc. is facing investigator findings regarding manufacturing compliance issues from the FDA.
- Eli Lilly and AstraZeneca are involved in drug development and market competition, with the FDA issuing approvals and legal actions involving both companies.
- FDA approval enables commercial availability for a product associated with Indianapolis.
- A facility located in St. George is operating under the standards set by the U.S. Food and Drug Administration (FDA) for supplement manufacturing.